Doug MacDonald

Doug MacDonald is a seasoned CMC Process Development Leader with over 20 years of experience in the biotechnology field. They have held key roles at various companies, including Senior Scientist at Dendreon, where they developed the HTPD platform and led downstream process development for cancer immunotherapies. Currently, they serve as the Director of Purification Process Development at Immunome, Inc., and have also held senior positions at notable companies such as Amgen and Seattle Genetics, managing CMC activities and contributing to regulatory submissions. Doug's expertise spans across protein purification, high-throughput screening, and process characterization, making them a valuable asset in the field of biologics development.